Stephanie Tan, MD | |
55 Arch St Ste 1b, Akron, OH 44304-1436 | |
(330) 375-3315 | |
(330) 375-3760 |
Full Name | Stephanie Tan |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 30 Years |
Location | 55 Arch St Ste 1b, Akron, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104893213 | NPI | - | NPPES |
0837182 | Other | OH | MEDICARE ID |
2035256 | Medicaid | OH | |
577 | Other | OH | SUMMA INSURANCE |
729116 | Other | OH | BUCKEYE COMMUNITY HEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 35-06-9271T (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Summa Health System | Akron, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summa Physicians Inc | 2961303532 | 640 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received a $1.8 million order from a southern Louisiana hospital to provide its patient monitoring solution and ICS G2 enterprise connectivity software.
Astellas Pharma Inc. today announced that preliminary data from a Phase 1/2 trial on the safety, tolerability and efficacy of ASP2215, a selective inhibitor of FLT3/AXL, in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) were presented during an oral abstract session at the American Society of Clinical Oncology's annual meeting in Chicago.
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.
A new study published in the American Heart Journal used spectroscopic imaging techniques to ‘see' fatty plaques in the arteries of ancient mummies. This shows that the people of ancient times also had a high incidence of clogged arteries, showing that heart disease is of very old lineage.
› Verified 2 days ago
Entity Name | Summa Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received a $1.8 million order from a southern Louisiana hospital to provide its patient monitoring solution and ICS G2 enterprise connectivity software.
Astellas Pharma Inc. today announced that preliminary data from a Phase 1/2 trial on the safety, tolerability and efficacy of ASP2215, a selective inhibitor of FLT3/AXL, in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) were presented during an oral abstract session at the American Society of Clinical Oncology's annual meeting in Chicago.
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.
A new study published in the American Heart Journal used spectroscopic imaging techniques to ‘see' fatty plaques in the arteries of ancient mummies. This shows that the people of ancient times also had a high incidence of clogged arteries, showing that heart disease is of very old lineage.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Tan, MD 525 E Market St, Po Box 2090, Akron, OH 44304-1619 Ph: (330) 996-0347 | Stephanie Tan, MD 55 Arch St Ste 1b, Akron, OH 44304-1436 Ph: (330) 375-3315 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received a $1.8 million order from a southern Louisiana hospital to provide its patient monitoring solution and ICS G2 enterprise connectivity software.
Astellas Pharma Inc. today announced that preliminary data from a Phase 1/2 trial on the safety, tolerability and efficacy of ASP2215, a selective inhibitor of FLT3/AXL, in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) were presented during an oral abstract session at the American Society of Clinical Oncology's annual meeting in Chicago.
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.
A new study published in the American Heart Journal used spectroscopic imaging techniques to ‘see' fatty plaques in the arteries of ancient mummies. This shows that the people of ancient times also had a high incidence of clogged arteries, showing that heart disease is of very old lineage.
› Verified 2 days ago
Dr. Michael A Pelini, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |